Snowball logo
logo
ROG_logo

Roche Holding AG

-- FrFr0.00  (0%)
Estimate
EPS
16.03
Beta
0.211
Growth
Revenue, YoY
5.65%
Net income, YoY
25.43%
FCF, YoY
75.15%
Forecast
EPS (FWD)
21.742
About the company
Ticker
ROG
ISIN
CH0012032048
Country
Switzerland
Sector (GICS)
Healthcare
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Frequently asked questions

What sector does Roche Holding AG (ROG) operate in?

Roche Holding AG belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Roche Holding AG (ROG) Earnings Per Share (EPS)?

The trailing EPS is CHF 16.03, and the forward EPS is CHF 21.74.

What is Roche Holding AG (ROG) EBITDA?

Roche Holding AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 11.61 billion.

Does Roche Holding AG (ROG) pay dividends?

No. Roche Holding AG does not pay a dividend.

How did Roche Holding AG (ROG) perform in its most recent earnings report?

In the last report (March 31, 2026), Roche Holding AG posted an EPS surprise of -19.13% and a revenue surprise of -50.43%.

When is Roche Holding AG (ROG) next earnings report?

Roche Holding AG is expected to release its next earnings report on June 30, 2026.

What is Roche Holding AG (ROG) beta (volatility) score?

Roche Holding AG has a beta of 0.211, indicating lower volatility than the overall market.